Microbiology & Immunology

The Research Projects and Published Manuscripts

  1. Nazir T, Nazir SR, Shamim R., Sultana M, Riaz H, Zafarullah M, Taha N. Murine and humanized monoclonal antibodies and their Therapeutic applications. JPUMHS;2020;10:04,164-168. DOI: http://doi.org/10.46536/jpumhs/2020/10.02.280
  2. Azharul Islam, Saba Manzoor, Saeed Ur Rashid Nazir, Taha Nazir, Ruqaiya Rasheed Kayani, Humayun Riaz, Misbah Sultana, Nida Taha (2020). Biochemical Dynamics and Clinical Features of Novel Corona Virus (2019-nCoV). Alternative Therapies. 3470 Washington Drive Suite Eagan MN 55122 USA. April, 2020 – VOL. 26, NO. 8
  3. Nazir T, Taha N, Naveed S, Sadia H, Nazir SR, Rehman A, Farooq M. Efficacy and sensitivity of the Peg Interferon Alpha-3 million units against HCV-RNA Genotype 3A given to the confirmed of new and relapsed human patients. JPUMHS;2020;10(03)
  4. Taha Nazir, Saeed Ur Rashid Nazir, Misbah Sultana, Humayun Riaz, Muhammad Naeem Qaisar, Nida Taha, Muhammad Amer, Azharul Islam. Emerging Immunomodulation Technologies May Potential Improve the Clinical and Pharmaceutical Health Care. Int
  5. Taha Nazir, Saeed Ur Rashid Nazir, Azharul Islam, Misbah Sultana, Humayun Riaz, Nida Taha, Potential threat of New Delhi Metallo-Beta-Lactamase-1 Enzyme, Multi Drug Resistant and Extensive Drug Resistant (XDR) to achieve the Millennium Development Goals (MGD’s) in South East Asian Countries. Int. J. Pharm. Sci. Rev. Res., 61(2), March – April 2020; Article No. 15, Pages: 72-78
  6. Taha Nazir, Saeed Ur Rashid Nazir, Azharul Islam,  Misbah Sultana, Humayun Riaz, Muhammad Amer and Nida Taha. The Innovative Potential of Antibody Engineering Enhanced the Clinical Value of Immunotherapy. JPRI, 31(6): 1-13, 2019; Article no.JPRI.53603 (British Journal of Pharmaceutical Research, Past ISSN: 2231-2919, NLM ID: 101631759)
  7. Taha Nazir, Ruqaiya Rasheed kayani, Saeed Ur Rasheed Nazir, Syed Muzzammil Masoud Zaidi, Saba Manzoor, Nida Taha. Epidemiology, genomic evolution and molecular features of severe acute respiratory syndrome-related Coronavirus. Adv J Biomed Sci. 2019: Vol. 4. p. 3-7
  8. Nazir, Taha, Nida Taha, Azahrul Islam, Suraj Abraham, Adeel Mahmood, and Mazhar Mustafa. “Monocytopenia; Induction by Vinorelbine, Cisplatin and Doxorubicin in Breast, Non-Small Cell Lung and Cervix Cancer Patients.” International journal of health sciences 10, no. 4 (2016): 542.
  9. Taha Nazir. Racial Differences in Communication Apprehension and Inter-Professional Socialization in Community Pharmacy Practice. J App Pharm 2016, 8:2. 1000e110. http://dx.doi.org/10.4172/1920-4159.1000e110
  10. Dogar MZH, Nazir T, Akram H, Nasir-ud-Din A, Farooq M (2015) Molecular Study of Human HCV RNA by Real Time-Polymerase Chain Reaction, Viral Kit and Robogene Quantification. Cell Mol Biol 61: 118. doi: 10.4172/1165-158X.1000118
  11. Nazir T, Nida T, Hameed A, Islam A (2015) Drug Resistant Pattern of M. tuberculosis – An Emerging Threat for Public Health. Prensa Med Argent 2015, 101:6.  http://dx.doi.org/10.4172/lpma.1000194; doi:http://dx.doi.org/10.4172/lpma.1000194
  12. Taha Nazir, Nida Taha, Azharul Islam, Adeel Mahmood (2015), Potential threat of New Delhi Metallo-Beta-Lactamase-1  Enzyme, Multi Drug Resistant and Extensive Drug Resistant to achieve the Millennium Development Goals in South East Asian Countries. Pak J Pharm Sci (Accepted). Office of the Dean, Faculty of Pharmacy, University of Karachi, Karachi-75270, Pakistan. E.: pakjps@hotmail.com; pjps@uok.edu.pk; W.: http://www.pjps.pk/ 
  1. Taha Nazir, Suraj Abraham, Azharul Islam (2012). Emergence of potential superbug Mycobacterium tuberculosis, lessons from New Delhi Mutant-1 bacterial strains. International Journal of Health Sciences, Qassim University, Vol. 6, No. 1 (Jan 2012/ Safar 1433H);
  2. Taha N, Muhammad HR, Abdul H, Bashir A, Javed AQ, Haroon SK. Characterization of Resistant Isolates of M. Tuberculosis. Indian Journal of Pharmacy Practice; Vol. 4, Issue 3, Jul – Sep, 2011. p. 30-34. https://ijopp.org/v4/i3
  3. Taha Nazir, Abdul Hameed, Effat Shabbir, Javed Anver Qureshi. Isoniazid resistance of Mycobacterium tuberculosis isolated from human patients. African Journal of Microbiology Research. Vol. 5(25); 2011, pp. 4291-4295
  4. Taha Nazir, Habib-Ur-Rehman, Owais Omar, Tahir Aziz Mughal (2011). Neutropenia induction by vinorelbine alone and in combination with doxorubicin and cisplatin in cancer patients. HealthMED -ISSN 1986-8103 – Volume 5 / Number 3/ 2011. p 486-490. Microsoft Word – Nazir et al pdf (academicjournals.org)
  5. Taha Nazir, Abdul Hameed, Hadyat Rasool, Javed Anver Qureshi. (2010). Ethambutol resistance profile of Mycobacterium tuberculosis strains isolated from human patients. Brazillian Journal of Microbiology; Brazilian Journal of Microbiology – 41: 1065-1069. https://doi.org/10.1590/S1517-83822010000400026. https://www.scielo.br/j/bjm/a/3TLnQnfKtRVCk3W7JDKnkjK/?lang=en
  6. Tahira Mughal, Arifa Tahir, Sadia Qureshi, Taha Nazir, Mahwish Rasheed. Antibacterial activity of black tea against Streptococcus mutans and its synergism with antibiotics. J App Pharm 2 (2) : 60-67 (2010)
  7. Taha Nazir, Abdul Hameed, Effat Shabbir, Javed Anver Qureshi, Suraj Abraham. Rifampicne resistance profile of Mycobacterium tuberculosis strains isolated from human patients. Proc Pak Acad Scie. 2009; 46(3):131-136. b21c186bproc46-3-3.pdf (paspk.org)
  8. Taha Nazir, Mazhar Mustafa, Habib Ur Rehman, Tahir Aziz Mughal. (2010). Eosinopenia induction by vinorelbine alone and in Combination with doxorubicin and cisplatin in cancer Patients. Pharmacologyonline 3: 785-790. ISSN 1827-8620
  9. Taha Nazir, Abdul Hameed, Muhammad Shoaib Akhtar, Effat Shabbir, Javed Anver Qureshi, Abdul Malik and Muhammad Naeem Qaisar. (2008). Pyrazinamide resistance of Mycobacterium tuberculosis strains, isolatedfrom human patients. Pharmacologyonline 3: 948-957. ISSN 1827-8620